Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- For eye-area products we typically run microbiology limits testing (total aerobic count and yeast/mold) plus specified pathogen screening such as S. aureus, P. aeruginosa, and C. albicans.
- For preserved eye creams and essence-type eye patches, we also support preservative efficacy (microbial challenge) work via our microbiology challenge capability, and we can send samples to a qualified third-party lab if you need independent reports.
- For U.S. buyers we can provide batch release documentation support such as COA, microbiology test reports, and quality system evidence (ISO 9001:2015).
- If requested, we can also support statements/doc packs for REACH, no animal testing, and safety/irritation or clinical-testing documentation based on your claim strategy.
- MOQ is confirmed after formula and packaging are locked (eye patches can require higher MOQ due to pouch/printing setups).
- Sampling follows our confirm-sample step before mass production.
- Typical bulk production lead time is 10-20 working days once materials are ready; packaging ordering often drives the schedule (e.g., unit box about 15 days, mask/patch pouch about 15 days, glass bottle about 15 days, acrylic bottle about 30 days).
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.